AVTX SCHEDULE 13G: SEC filing
Filed with the SEC on · accession 0001493152-26-049273
AVTX filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 29, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +4.5% by the first close after the filing.
Summary of the filing
Trails Edge Capital Partners, LP, Trails Edge Biotechnology Master Fund, LP, and Ortav Yehudai filed a joint Schedule 13G regarding their beneficial ownership of Avalo Therapeutics, Inc. common stock.
Key details
How AVTX stock reacted
Close before
$7.12
Oct 28, 2026
First close after
+4.49%
$7.44
5 trading days
-0.70%
$7.07
Since filing
-2.67%
$6.93
✦ Ask GOAX AI about this filing — what it means for AVTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AVTX?
Click hereFrequently asked questions
What did AVTX file with the SEC on Oct 29, 2026?
AVTX filed a SCHEDULE 13G (SEC filing). Trails Edge Capital Partners, LP, Trails Edge Biotechnology Master Fund, LP, and Ortav Yehudai filed a joint Schedule 13G regarding their beneficial ownership of Avalo Therapeutics, Inc. common stock.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did AVTX stock react to this filing?
AVTX closed at $7.12 before the filing and $7.44 on Oct 29, 2026 (+4.49%). Five trading days later: $7.07 (-0.70%).
Other AVTX SEC filings
- 8-K · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 5, 2026
- 424B5 · Shelf registrationNov 5, 2026
- 8-K · Guidance cutAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 424B3 · Secondary offeringJul 28, 2026
- S-3 · Shelf registrationJul 17, 2026
- 8-K · Board changeJun 23, 2026
- 8-K · SEC filingJun 16, 2026
Get alerts when AVTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days